Literature DB >> 23625293

Catechins in dietary supplements and hepatotoxicity.

Victor J Navarro1, Herbert L Bonkovsky, Sun-Il Hwang, Maricruz Vega, Huiman Barnhart, Jose Serrano.   

Abstract

BACKGROUND: Many herbal dietary supplements (HDS) contain green tea extract (GTE) and its component catechins, although their presence may not always be indicated on the product label.
PURPOSE: Because GTE and catechins have been implicated in human hepatotoxicity in several case reports, our objective was to determine whether catechins were present in HDS that were implicated in hepatotoxicity, even if not identified among the labeled ingredients, and whether these compounds could be associated with liver injury.
METHODS: We assayed 97 HDS implicated in human hepatotoxicity for catechins.
RESULTS: We found that 29 of 73 HDS (39.7%) that did not identify GTE or any of its component catechins on their label contained catechins. Among patients with confirmed hepatotoxicity, there was no statistically significant association between the presence of catechin or the dose consumed and liver injury causality score, severity, or pattern of liver injury. Catechin levels tended to be highest in products used for weight loss, although catechin concentrations were low in most products.
CONCLUSIONS: Many HDS commonly contain catechins that are implicated in hepatotoxicity, although their presence may not be indicated on the product label. Although our results did not establish an association between GTE or catechins with hepatotoxicity, they highlight some of the many complexities and uncertainties that surround the attribution of drug-induced liver injury (DILI) to HDS.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23625293      PMCID: PMC3769469          DOI: 10.1007/s10620-013-2687-9

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  26 in total

1.  Adulteration of dietary supplements.

Authors:  Morgan R Cole; C W Fetrow
Journal:  Am J Health Syst Pharm       Date:  2003-08-01       Impact factor: 2.637

2.  The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry.

Authors:  Sandra Ciesek; Thomas von Hahn; Che C Colpitts; Luis M Schang; Martina Friesland; Jörg Steinmann; Michael P Manns; Michael Ott; Heiner Wedemeyer; Philip Meuleman; Thomas Pietschmann; Eike Steinmann
Journal:  Hepatology       Date:  2011-12       Impact factor: 17.425

3.  Fulminant hepatitis during self-medication with hydroalcoholic extract of green tea.

Authors:  Romain Gloro; Isabelle Hourmand-Ollivier; Brigitte Mosquet; Laurent Mosquet; Pierre Rousselot; Ephrem Salamé; Marie-Astrid Piquet; Thông Dao
Journal:  Eur J Gastroenterol Hepatol       Date:  2005-10       Impact factor: 2.566

4.  Hepatotoxicity associated with supplements containing Chinese green tea (Camellia sinensis).

Authors:  Herbert L Bonkovsky
Journal:  Ann Intern Med       Date:  2006-01-03       Impact factor: 25.391

Review 5.  Green tea catechins as novel antitumor and antiangiogenic compounds.

Authors:  Michel Demeule; Jonathan Michaud-Levesque; Borhane Annabi; Denis Gingras; Dominique Boivin; Julie Jodoin; Sylvie Lamy; Yanick Bertrand; Richard Béliveau
Journal:  Curr Med Chem Anticancer Agents       Date:  2002-07

6.  Phase I trial of oral green tea extract in adult patients with solid tumors.

Authors:  K M Pisters; R A Newman; B Coldman; D M Shin; F R Khuri; W K Hong; B S Glisson; J S Lee
Journal:  J Clin Oncol       Date:  2001-03-15       Impact factor: 44.544

7.  Green tea composition, consumption, and polyphenol chemistry.

Authors:  H N Graham
Journal:  Prev Med       Date:  1992-05       Impact factor: 4.018

8.  Cellular and in vivo hepatotoxicity caused by green tea phenolic acids and catechins.

Authors:  Giuseppe Galati; Alison Lin; Amira M Sultan; Peter J O'Brien
Journal:  Free Radic Biol Med       Date:  2005-11-09       Impact factor: 7.376

9.  Hepatic injury in 12 patients taking the herbal weight loss AIDS Chaso or Onshido.

Authors:  Masayuki Adachi; Hidetsugu Saito; Hisashi Kobayashi; Yoshinori Horie; Shinzo Kato; Masahiro Yoshioka; Hiromasa Ishii
Journal:  Ann Intern Med       Date:  2003-09-16       Impact factor: 25.391

10.  A single ascending dose study of epigallocatechin gallate in healthy volunteers.

Authors:  U Ullmann; J Haller; J P Decourt; N Girault; J Girault; A S Richard-Caudron; B Pineau; P Weber
Journal:  J Int Med Res       Date:  2003 Mar-Apr       Impact factor: 1.671

View more
  34 in total

1.  Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset.

Authors:  Robert J Fontana; Paul H Hayashi; Jiezhun Gu; K Rajender Reddy; Huiman Barnhart; Paul B Watkins; Jose Serrano; William M Lee; Naga Chalasani; Andrew Stolz; Timothy Davern; Jayant A Talwakar
Journal:  Gastroenterology       Date:  2014-03-27       Impact factor: 22.682

2.  Feasibility of including green tea products for an analytically verified dietary supplement database.

Authors:  Leila Saldanha; Johanna Dwyer; Karen Andrews; Joseph Betz; James Harnly; Pamela Pehrsson; Catherine Rimmer; Sushma Savarala
Journal:  J Food Sci       Date:  2015-03-26       Impact factor: 3.167

Review 3.  Herbal and Dietary Supplement-Induced Liver Injury.

Authors:  Ynto S de Boer; Averell H Sherker
Journal:  Clin Liver Dis       Date:  2016-10-14       Impact factor: 6.126

4.  Epigallocatechin Gallate Induces Hepatic Stellate Cell Senescence and Attenuates Development of Hepatocellular Carcinoma.

Authors:  Mozhdeh Sojoodi; Lan Wei; Derek J Erstad; Suguru Yamada; Tsutomu Fujii; Hadassa Hirschfield; Rosa S Kim; Gregory Y Lauwers; Michael Lanuti; Yujin Hoshida; Kenneth K Tanabe; Bryan C Fuchs
Journal:  Cancer Prev Res (Phila)       Date:  2020-04-06

5.  Ashwagandha-induced liver injury: A case series from Iceland and the US Drug-Induced Liver Injury Network.

Authors:  Helgi K Björnsson; Einar S Björnsson; Bharathi Avula; Ikhlas A Khan; Jon G Jonasson; Marwan Ghabril; Paul H Hayashi; Victor Navarro
Journal:  Liver Int       Date:  2020-02-11       Impact factor: 5.828

6.  Sensitivity to hepatotoxicity due to epigallocatechin gallate is affected by genetic background in diversity outbred mice.

Authors:  Rachel J Church; Daniel M Gatti; Thomas J Urban; Nanye Long; Xi Yang; Qiang Shi; J Scott Eaddy; Merrie Mosedale; Shawn Ballard; Gary A Churchill; Victor Navarro; Paul B Watkins; David W Threadgill; Alison H Harrill
Journal:  Food Chem Toxicol       Date:  2014-11-28       Impact factor: 6.023

7.  The safety of green tea extract supplementation in postmenopausal women at risk for breast cancer: results of the Minnesota Green Tea Trial.

Authors:  Allison M Dostal; Hamed Samavat; Sarah Bedell; Carolyn Torkelson; Renwei Wang; Karen Swenson; Chap Le; Anna H Wu; Giske Ursin; Jian-Min Yuan; Mindy S Kurzer
Journal:  Food Chem Toxicol       Date:  2015-06-05       Impact factor: 6.023

Review 8.  Liver injury from herbal and dietary supplements.

Authors:  Victor J Navarro; Ikhlas Khan; Einar Björnsson; Leonard B Seeff; Jose Serrano; Jay H Hoofnagle
Journal:  Hepatology       Date:  2016-11-17       Impact factor: 17.425

9.  Risk of Liver Injury Associated with Green Tea Extract in SLIMQUICK(®) Weight Loss Products: Results from the DILIN Prospective Study.

Authors:  Elizabeth X Zheng; Simona Rossi; Robert J Fontana; Raj Vuppalanchi; Jay H Hoofnagle; Ikhlas Khan; Victor J Navarro
Journal:  Drug Saf       Date:  2016-08       Impact factor: 5.606

10.  Severe Acute Hepatocellular Injury Attributed to OxyELITE Pro: A Case Series.

Authors:  Lauren A Heidemann; Victor J Navarro; Jawad Ahmad; Paul H Hayashi; Andrew Stolz; David E Kleiner; Robert J Fontana
Journal:  Dig Dis Sci       Date:  2016-05-03       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.